Kevin Kayvan Zarrabi, Susan F. Slovin, William J. Tester, Benjamin E. Leiby, Shannon Pileggi, Karen E. Knudsen, David C. Smith, Gurkamal S. Chatta, Karen A. Autio, Wassim Abida, Howard I. Scher, Michael J. Morris, William Kevin Kelly. "A randomized phase Ib/II study of enzalutamide (Enza) with and without ribociclib (Rib) in patients with metastatic castrate-resistant prostate cancer (mCRPC) that retains RB expression: RiboX study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.5057